![Karin Walker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 93 500 $ in data 31/08/2026
Karin L.
Walker currently works at Prothena Corp.
Plc, as Chief Accounting Officer.
Ms. Walker also formerly worked at LifeSci Acquisition Corp., as Independent Directors in 2020, Cyclacel Pharmaceuticals, Inc., as Independent Non-Executive Director from 2020 to 2025, Affymax, Inc., as Chief Accounting Officer & Vice President-Finance from 2012 to 2013, Ernst & Young US LLP, as Accountant, CV Therapeutics, Inc., as Vice President-Finance & Controller from 2006 to 2009, and Amyris, Inc., as Vice President-Finance & Controller from 2009 to 2012.
Ms. Walker received her undergraduate degree from California Polytechnic State University (San Luis Obispo).
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
PROTHENA CORP. PLC 0,02% | 28/07/2026 | 10.000 ( 0,02% ) | 93 500 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| PROTHENA CORPORATION PLC | Comptroller/Controller/Auditor | 20/05/2013 |
| Società | Posizione | Fine |
|---|---|---|
| BIO GREEN MED SOLUTION, INC. | Direttore/Membro del Consiglio | 03/01/2025 |
| VINCERX PHARMA, INC. | Direttore/Membro del Consiglio | 23/12/2020 |
| AFFYMAX, INC. | Comptroller/Controller/Auditor | 01/05/2013 |
| AMYRIS, INC. | Comptroller/Controller/Auditor | 01/09/2012 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Comptroller/Controller/Auditor | 01/08/2009 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
Amyris, Inc.
 Amyris, Inc. Chemicals: SpecialtyProcess Industries Operates as a biomanufacturing company that uses renewable biological chemistry | Process Industries |
Affymax, Inc.
 Affymax, Inc. BiotechnologyHealth Technology Develops and distributes pharmaceutical products | Health Technology |
California Polytechnic State University (San Luis Obispo)
 California Polytechnic State University (San Luis Obispo) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cyclacel Pharmaceuticals, Inc.
 Cyclacel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes mechanism-targeted drugs to treat human cancers | Health Technology |
Prothena Corp. Plc
 Prothena Corp. Plc BiotechnologyHealth Technology Focuses on the discovery and development of novel antibodies | Health Technology |
Ernst & Young US LLP
 Ernst & Young US LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
LifeSci Acquisition Corp.
 LifeSci Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
